Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heffner

Showing results (811-820 of 1,030) with videos related to

Pageof 103
Sort By:
Emergency Medicine Journal : EMJ|August 22, 2013
Is the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative?Paul Walsh, Christina Overmyer, Christine Hancock, et al.
Trials|December 1, 2019
Structured, proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic, randomized controlled trialMarc Kowalkowski, Shih-Hsiung Chou, Andrew McWilliams, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Chest|December 11, 2003
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologistsY C Gary Lee, Michael H Baumann, Nick A Maskell, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Contemporary Clinical Trials|November 15, 2021
Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH)Jennifer B McClure, Sheryl L Catz, Clementine Chalal, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 24, 2014
Risk and protective factors associated with substance use disorders in adolescents with first-episode maniaJacob R Stephens, Jaimee L Heffner, Caleb M Adler, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Neurosurgery|August 5, 2017
Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009Brandon A McCutcheon, Brian R Hirshman, Brandon C Gabel, et al.
Pageof 103

Showing results (811-820 of 1,030) with videos related to

Sort By:
Pageof 103
Emergency Medicine Journal : EMJ|August 22, 2013
Is the interpretation of rapid antigen testing for respiratory syncytial virus as simple as positive or negative?Paul Walsh, Christina Overmyer, Christine Hancock, et al.
Trials|December 1, 2019
Structured, proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic, randomized controlled trialMarc Kowalkowski, Shih-Hsiung Chou, Andrew McWilliams, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Chest|December 11, 2003
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologistsY C Gary Lee, Michael H Baumann, Nick A Maskell, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Contemporary Clinical Trials|November 15, 2021
Design and methods of a randomized trial testing the novel Wellness Intervention for Smokers Living with HIV (WISH)Jennifer B McClure, Sheryl L Catz, Clementine Chalal, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 24, 2014
Risk and protective factors associated with substance use disorders in adolescents with first-episode maniaJacob R Stephens, Jaimee L Heffner, Caleb M Adler, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Neurosurgery|August 5, 2017
Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009Brandon A McCutcheon, Brian R Hirshman, Brandon C Gabel, et al.
Pageof 103